HI
Hikma Pharma
HIK.L·LSELondon UKFounded 19788,500 employees
Mid CappharmaPublicInfectious DiseaseOncology
Platform: Injectable Gen
Market Cap
$5B
All Drugs
3
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (HIK.L)
Loading HIK.L stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Rimanaritide | HIK-1049 | Phase 2/3 | 1 | CDK4/6 | NASHHS | ||
| Geliderotide | HIK-1408 | Phase 2 | 2 | SMN2 | CholangiocarcinomaLN | ||
| HIK-6819 | HIK-6819 | Preclinical | 1 | TIM-3 | Wet AMD |
SEC Filings & Financial Documents
SEC filings are not available for LSE-listed companies.
Hikma Pharma trades on LSE (GB). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)